Industry: Service & Software
Published Date: 2025-07-31
Pages: 145 Pages
Report ld: 4815473
Request Sample
Customized Report
Cell Line STR Identification Market Size(US$)

CAGR 2025-2031
7.0%
Market Size,2031
USD 568
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Cell Line STR Identification market is projected to grow from US$ 356 million in 2024 to US$ 568 million by 2031, at a CAGR of 7.0% (2025-2031), driven by critical product segments and diverse end‑use applications.
Verifying the identity and purity of human cell lines is essential to the integrity of research activities. Companies in the cell line authentication and characterization tests market are increasing R&D in human cell authentication assays that identify short term repeat (STR) markers. Stakeholders in the cell line authentication and characterization tests market are making use of multiplex polymerase chain reaction (PCR) to simultaneously amplify the amelogenin gene and some of the most informative polymorphic markers in the human genome.
From a downstream perspective, Microbial Contamination accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Cell Line STR Identification leading manufacturers including Bio-Synthesis, Inc., Cell Line Genetics, Inc., Charles River Laboratories, DNA Forensics Lab India, Eurofins Genomics (Eurofins Scientific), GenomeScan, IDEXX Laboratories, Inc., Laboratory Corporation of America Holdings, Microsynth AG, NorthGene Limited (Biofortuna Limited), etc., dominate supply; the top five capture approximately % of global revenue, with Bio-Synthesis, Inc. leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Cell Line STR Identification market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the Cell Line STR Identification study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Cell Line STR Identification: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Cell Line STR Identification Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Short Tandem Repeat (STR) Analysis
1.2.3 Single Nucleotide Polymorphism (SNP) Analysis
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Cell Line STR Identification Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Microbial Contamination
1.3.3 Cell Line Identity
1.3.4 Genetic Stability
1.3.5 Virus Testing
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Cell Line STR Identification Revenue Estimates and Forecasts 2020-2031
2.2 Global Cell Line STR Identification Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Cell Line STR Identification Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Cell Line STR Identification Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Short Tandem Repeat (STR) Analysis Market Size by Players
3.3.2 Single Nucleotide Polymorphism (SNP) Analysis Market Size by Players
3.3.3 Others Market Size by Players
3.4 Global Cell Line STR Identification Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Cell Line STR Identification Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Cell Line STR Identification Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Cell Line STR Identification Market Size by Type (2020-2031)
6.4 North America Cell Line STR Identification Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Cell Line STR Identification Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Cell Line STR Identification Market Size by Type (2020-2031)
7.4 Europe Cell Line STR Identification Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Cell Line STR Identification Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Cell Line STR Identification Market Size by Type (2020-2031)
8.4 Asia-Pacific Cell Line STR Identification Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Cell Line STR Identification Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Cell Line STR Identification Market Size by Type (2020-2031)
9.4 Central and South America Cell Line STR Identification Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Cell Line STR Identification Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Cell Line STR Identification Market Size by Type (2020-2031)
10.4 Middle East and Africa Cell Line STR Identification Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Cell Line STR Identification Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Bio-Synthesis, Inc.
11.1.1 Bio-Synthesis, Inc. Corporation Information
11.1.2 Bio-Synthesis, Inc. Business Overview
11.1.3 Bio-Synthesis, Inc. Cell Line STR Identification Product Features and Attributes
11.1.4 Bio-Synthesis, Inc. Cell Line STR Identification Revenue and Gross Margin (2020-2025)
11.1.5 Bio-Synthesis, Inc. Cell Line STR Identification Revenue by Product in 2024
11.1.6 Bio-Synthesis, Inc. Cell Line STR Identification Revenue by Application in 2024
11.1.7 Bio-Synthesis, Inc. Cell Line STR Identification Revenue by Geographic Area in 2024
11.1.8 Bio-Synthesis, Inc. Cell Line STR Identification SWOT Analysis
11.1.9 Bio-Synthesis, Inc. Recent Developments
11.2 Cell Line Genetics, Inc.
11.2.1 Cell Line Genetics, Inc. Corporation Information
11.2.2 Cell Line Genetics, Inc. Business Overview
11.2.3 Cell Line Genetics, Inc. Cell Line STR Identification Product Features and Attributes
11.2.4 Cell Line Genetics, Inc. Cell Line STR Identification Revenue and Gross Margin (2020-2025)
11.2.5 Cell Line Genetics, Inc. Cell Line STR Identification Revenue by Product in 2024
11.2.6 Cell Line Genetics, Inc. Cell Line STR Identification Revenue by Application in 2024
11.2.7 Cell Line Genetics, Inc. Cell Line STR Identification Revenue by Geographic Area in 2024
11.2.8 Cell Line Genetics, Inc. Cell Line STR Identification SWOT Analysis
11.2.9 Cell Line Genetics, Inc. Recent Developments
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Corporation Information
11.3.2 Charles River Laboratories Business Overview
11.3.3 Charles River Laboratories Cell Line STR Identification Product Features and Attributes
11.3.4 Charles River Laboratories Cell Line STR Identification Revenue and Gross Margin (2020-2025)
11.3.5 Charles River Laboratories Cell Line STR Identification Revenue by Product in 2024
11.3.6 Charles River Laboratories Cell Line STR Identification Revenue by Application in 2024
11.3.7 Charles River Laboratories Cell Line STR Identification Revenue by Geographic Area in 2024
11.3.8 Charles River Laboratories Cell Line STR Identification SWOT Analysis
11.3.9 Charles River Laboratories Recent Developments
11.4 DNA Forensics Lab India
11.4.1 DNA Forensics Lab India Corporation Information
11.4.2 DNA Forensics Lab India Business Overview
11.4.3 DNA Forensics Lab India Cell Line STR Identification Product Features and Attributes
11.4.4 DNA Forensics Lab India Cell Line STR Identification Revenue and Gross Margin (2020-2025)
11.4.5 DNA Forensics Lab India Cell Line STR Identification Revenue by Product in 2024
11.4.6 DNA Forensics Lab India Cell Line STR Identification Revenue by Application in 2024
11.4.7 DNA Forensics Lab India Cell Line STR Identification Revenue by Geographic Area in 2024
11.4.8 DNA Forensics Lab India Cell Line STR Identification SWOT Analysis
11.4.9 DNA Forensics Lab India Recent Developments
11.5 Eurofins Genomics (Eurofins Scientific)
11.5.1 Eurofins Genomics (Eurofins Scientific) Corporation Information
11.5.2 Eurofins Genomics (Eurofins Scientific) Business Overview
11.5.3 Eurofins Genomics (Eurofins Scientific) Cell Line STR Identification Product Features and Attributes
11.5.4 Eurofins Genomics (Eurofins Scientific) Cell Line STR Identification Revenue and Gross Margin (2020-2025)
11.5.5 Eurofins Genomics (Eurofins Scientific) Cell Line STR Identification Revenue by Product in 2024
11.5.6 Eurofins Genomics (Eurofins Scientific) Cell Line STR Identification Revenue by Application in 2024
11.5.7 Eurofins Genomics (Eurofins Scientific) Cell Line STR Identification Revenue by Geographic Area in 2024
11.5.8 Eurofins Genomics (Eurofins Scientific) Cell Line STR Identification SWOT Analysis
11.5.9 Eurofins Genomics (Eurofins Scientific) Recent Developments
11.6 GenomeScan
11.6.1 GenomeScan Corporation Information
11.6.2 GenomeScan Business Overview
11.6.3 GenomeScan Cell Line STR Identification Product Features and Attributes
11.6.4 GenomeScan Cell Line STR Identification Revenue and Gross Margin (2020-2025)
11.6.5 GenomeScan Recent Developments
11.7 IDEXX Laboratories, Inc.
11.7.1 IDEXX Laboratories, Inc. Corporation Information
11.7.2 IDEXX Laboratories, Inc. Business Overview
11.7.3 IDEXX Laboratories, Inc. Cell Line STR Identification Product Features and Attributes
11.7.4 IDEXX Laboratories, Inc. Cell Line STR Identification Revenue and Gross Margin (2020-2025)
11.7.5 IDEXX Laboratories, Inc. Recent Developments
11.8 Laboratory Corporation of America Holdings
11.8.1 Laboratory Corporation of America Holdings Corporation Information
11.8.2 Laboratory Corporation of America Holdings Business Overview
11.8.3 Laboratory Corporation of America Holdings Cell Line STR Identification Product Features and Attributes
11.8.4 Laboratory Corporation of America Holdings Cell Line STR Identification Revenue and Gross Margin (2020-2025)
11.8.5 Laboratory Corporation of America Holdings Recent Developments
11.9 Microsynth AG
11.9.1 Microsynth AG Corporation Information
11.9.2 Microsynth AG Business Overview
11.9.3 Microsynth AG Cell Line STR Identification Product Features and Attributes
11.9.4 Microsynth AG Cell Line STR Identification Revenue and Gross Margin (2020-2025)
11.9.5 Microsynth AG Recent Developments
11.10 NorthGene Limited (Biofortuna Limited)
11.10.1 NorthGene Limited (Biofortuna Limited) Corporation Information
11.10.2 NorthGene Limited (Biofortuna Limited) Business Overview
11.10.3 NorthGene Limited (Biofortuna Limited) Cell Line STR Identification Product Features and Attributes
11.10.4 NorthGene Limited (Biofortuna Limited) Cell Line STR Identification Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Perfectus Biomed Limited
11.11.1 Perfectus Biomed Limited Corporation Information
11.11.2 Perfectus Biomed Limited Business Overview
11.11.3 Perfectus Biomed Limited Cell Line STR Identification Product Features and Attributes
11.11.4 Perfectus Biomed Limited Cell Line STR Identification Revenue and Gross Margin (2020-2025)
11.11.5 Perfectus Biomed Limited Recent Developments
11.12 Promega Corporation
11.12.1 Promega Corporation Corporation Information
11.12.2 Promega Corporation Business Overview
11.12.3 Promega Corporation Cell Line STR Identification Product Features and Attributes
11.12.4 Promega Corporation Cell Line STR Identification Revenue and Gross Margin (2020-2025)
11.12.5 Promega Corporation Recent Developments
11.13 SGS SA
11.13.1 SGS SA Corporation Information
11.13.2 SGS SA Business Overview
11.13.3 SGS SA Cell Line STR Identification Product Features and Attributes
11.13.4 SGS SA Cell Line STR Identification Revenue and Gross Margin (2020-2025)
11.13.5 SGS SA Recent Developments
11.14 Sigma-Aldrich Co. LLC. (Merck KGaA)
11.14.1 Sigma-Aldrich Co. LLC. (Merck KGaA) Corporation Information
11.14.2 Sigma-Aldrich Co. LLC. (Merck KGaA) Business Overview
11.14.3 Sigma-Aldrich Co. LLC. (Merck KGaA) Cell Line STR Identification Product Features and Attributes
11.14.4 Sigma-Aldrich Co. LLC. (Merck KGaA) Cell Line STR Identification Revenue and Gross Margin (2020-2025)
11.14.5 Sigma-Aldrich Co. LLC. (Merck KGaA) Recent Developments
11.15 Thermo Fisher Scientific, Inc.
11.15.1 Thermo Fisher Scientific, Inc. Corporation Information
11.15.2 Thermo Fisher Scientific, Inc. Business Overview
11.15.3 Thermo Fisher Scientific, Inc. Cell Line STR Identification Product Features and Attributes
11.15.4 Thermo Fisher Scientific, Inc. Cell Line STR Identification Revenue and Gross Margin (2020-2025)
11.15.5 Thermo Fisher Scientific, Inc. Recent Developments
12 Cell Line STR IdentificationIndustry Chain Analysis
12.1 Cell Line STR Identification Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Cell Line STR Identification Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Cell Line STR Identification Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Cell Line STR Identification market is projected to grow from US$ 378 million in 2025 to US$ 604 million by 2032, at a CAGR of 7.0% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-24
Pages: 142
USD 4900.00
(Single User License)
The global Cell Line STR Identification market size was US$ 378 million in 2025 and is forecast to reach a readjusted size of US$ 604 million by 2032 with a CAGR of 7.0% during the forecast period 2026-2032.
Published Date: 2026-03-24
Pages: 92
USD 4250.00
(Single User License)
The global market for Cell Line STR Identification was estimated to be worth US$ 378 million in 2025 and is projected to reach US$ 604 million, growing at a CAGR of 7.0% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 114
USD 3950.00
(Single User License)
The global Cell Line STR Identification market was valued at US$ 378 million in 2025 and is anticipated to reach US$ 604 million by 2032, at a CAGR of 7.0% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 115
USD 2900.00
(Single User License)
The global Cell Line STR Identification market size was US$ 356 million in 2024 and is forecast to a readjusted size of US$ 568 million by 2031 with a CAGR of 7.0% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 98
USD 4250.00
(Single User License)
The global market for Cell Line STR Identification was estimated to be worth US$ 356 million in 2024 and is forecast to a readjusted size of US$ 568 million by 2031 with a CAGR of 7.0% during the forecast period 2025-2031.
Published Date: 2025-03-12
Pages: 108
USD 3950.00
(Single User License)
The global market for Cell Line STR Identification was valued at US$ 356 million in the year 2024 and is projected to reach a revised size of US$ 568 million by 2031, growing at a CAGR of 7.0% during the forecast period.
Published Date: 2025-03-12
Pages: 90
USD 2900.00
(Single User License)
The global market for Cell Line STR Identification was estimated to be worth US$ 356 million in 2024 and is forecast to a readjusted size of US$ 568 million by 2031 with a CAGR of 7.0% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 116
USD 3950.00
(Single User License)
The global market for Cell Line STR Identification was valued at US$ 341 million in the year 2023 and is projected to reach a revised size of US$ 534 million by 2030, growing at a CAGR of 7.0% during the forecast period.
Published Date: 2025-01-04
Pages: 88
USD 2900.00
(Single User License)
The global market for Cell Line STR Identification was estimated to be worth US$ 341 million in 2023 and is forecast to a readjusted size of US$ 534 million by 2030 with a CAGR of 7.0% during the forecast period 2024-2030.
Published Date: 2025-01-04
Pages: 119
USD 3950.00
(Single User License)
The global Cell Line STR Identification market is projected to grow from US$ 378 million in 2025 to US$ 604 million by 2032, at a CAGR of 7.0% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-24
Pages: 142
The global Cell Line STR Identification market size was US$ 378 million in 2025 and is forecast to reach a readjusted size of US$ 604 million by 2032 with a CAGR of 7.0% during the forecast period 2026-2032.
Published: 2026-03-24
Pages: 92
The global market for Cell Line STR Identification was estimated to be worth US$ 378 million in 2025 and is projected to reach US$ 604 million, growing at a CAGR of 7.0% from 2026 to 2032.
Published: 2026-01-19
Pages: 114
The global Cell Line STR Identification market was valued at US$ 378 million in 2025 and is anticipated to reach US$ 604 million by 2032, at a CAGR of 7.0% from 2026 to 2032.
Published: 2026-01-08
Pages: 115
The global Cell Line STR Identification market size was US$ 356 million in 2024 and is forecast to a readjusted size of US$ 568 million by 2031 with a CAGR of 7.0% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 98
The global market for Cell Line STR Identification was estimated to be worth US$ 356 million in 2024 and is forecast to a readjusted size of US$ 568 million by 2031 with a CAGR of 7.0% during the forecast period 2025-2031.
Published: 2025-03-12
Pages: 108
The global market for Cell Line STR Identification was valued at US$ 356 million in the year 2024 and is projected to reach a revised size of US$ 568 million by 2031, growing at a CAGR of 7.0% during the forecast period.
Published: 2025-03-12
Pages: 90
The global market for Cell Line STR Identification was estimated to be worth US$ 356 million in 2024 and is forecast to a readjusted size of US$ 568 million by 2031 with a CAGR of 7.0% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 116
The global market for Cell Line STR Identification was valued at US$ 341 million in the year 2023 and is projected to reach a revised size of US$ 534 million by 2030, growing at a CAGR of 7.0% during the forecast period.
Published: 2025-01-04
Pages: 88
The global market for Cell Line STR Identification was estimated to be worth US$ 341 million in 2023 and is forecast to a readjusted size of US$ 534 million by 2030 with a CAGR of 7.0% during the forecast period 2024-2030.
Published: 2025-01-04
Pages: 119
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now